Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Tafenoquine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,268Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    60 Degrees, Tulane to Study Tafenoquine for Lyme, Others
    60 Degrees, Tulane to Study Tafenoquine for Lyme, Others

    17 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/17/3117175/0/en/60-Degrees-Pharmaceuticals-and-Tulane-University-Sign-Research-Agreement-to-Study-Tafenoquine-Against-Lyme-and-Bartonella-Bacteria.html

    GLOBENEWSWIRE
    17 Jul 2025
    Share Share
    60 Degrees Adds ARAKODA 8-Count Pack for Malaria Prevention
    60 Degrees Adds ARAKODA 8-Count Pack for Malaria Prevention

    04 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/04/3093580/0/en/60-Degrees-Pharmaceuticals-Expands-Options-for-Malaria-Prevention-with-Introduction-of-ARAKODA-tafenoquine-8-Count-Bottle-Format.html

    GLOBENEWSWIRE
    04 Jun 2025
    Share Share
    60 Degrees Pharma Partners with Yale for Tafenoquine Development
    60 Degrees Pharma Partners with Yale for Tafenoquine Development

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057618/0/en/Sixty-Degrees-Pharmaceuticals-Announces-Patent-License-Agreement-to-Advance-Development-of-Tafenoquine-for-Babesiosis-Treatment-and-Prevention-with-Yale-School-of-Medicine-and-Yale.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share
    Sixty Degrees Ensures Tafenoquine Supply With KODATEF Import
    Sixty Degrees Ensures Tafenoquine Supply With KODATEF Import

    11 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/11/3024516/0/en/Sixty-Degrees-Pharmaceuticals-to-Ensure-Continuity-of-Tafenoquine-Supply-in-U-S-by-Importing-Limited-Quantity-of-KODATEF.html

    GLOBENEWSWIRE
    11 Feb 2025
    Share Share
    60 Degrees Pharma IRB Approved For Tafenoquine Babesiosis Study
    60 Degrees Pharma IRB Approved For Tafenoquine Babesiosis Study

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016354/0/en/60-Degrees-Pharma-Announces-IRB-Approval-of-Phase-II-Study-to-Evaluate-Tafenoquine-for-Chronic-Babesiosis.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    60 Degrees Enrolls 1st Patient In Tafenoquine Babesiosis Study
    60 Degrees Enrolls 1st Patient In Tafenoquine Babesiosis Study

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006241/0/en/60-Degrees-Pharmaceuticals-Enrolls-First-Patient-in-Tafenoquine-Expanded-Access-Clinical-Study-for-Persistent-B-microti-Babesiosis.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share